Torrent Pharmaceuticals Limited

NSEI:TORNTPHARM Rapport sur les actions

Capitalisation boursière : ₹1.1t

Torrent Pharmaceuticals Gestion

Gestion contrôle des critères 2/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Samir Mehta

Directeur général

₹260.0m

Rémunération totale

Pourcentage du salaire du PDG0.02%
Durée du mandat du directeur général35.8yrs
Propriété du PDG0.0002%
Durée moyenne d'occupation des postes de direction2.3yrs
Durée moyenne du mandat des membres du conseil d'administration2.4yrs

Mises à jour récentes de la gestion

Recent updates

Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

Oct 29
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts

Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing

Oct 24
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing

Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets

Jul 26
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets

Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Apr 16
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Mar 03
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Feb 05
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00

Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Jan 07
Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly

Nov 14
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jun 01
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Mar 01
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jul 25
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture

Jun 02
Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture

Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

May 25
Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Feb 18
A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00

Jan 27
Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00

Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly

Jan 04
Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly

Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock

Dec 14
Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock

A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Nov 07
A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Sep 30
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?

Sep 01
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?

Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

Jul 02
Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly

I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease

Jun 01
I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease

Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate

May 14
Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate

Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Mar 23
Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?

Analyse de la rémunération des PDG

Comment la rémunération de Samir Mehta a-t-elle évolué par rapport aux bénéfices de Torrent Pharmaceuticals?
DateRémunération totaleSalaireBénéfices de l'entreprise
Sep 30 2024n/an/a

₹18b

Jun 30 2024n/an/a

₹17b

Mar 31 2024₹260m₹40k

₹17b

Dec 31 2023n/an/a

₹15b

Sep 30 2023n/an/a

₹13b

Jun 30 2023n/an/a

₹13b

Mar 31 2023₹230m₹40k

₹12b

Dec 31 2022n/an/a

₹8b

Sep 30 2022n/an/a

₹8b

Jun 30 2022n/an/a

₹8b

Mar 31 2022₹200m₹40k

₹8b

Dec 31 2021n/an/a

₹12b

Sep 30 2021n/an/a

₹13b

Jun 30 2021n/an/a

₹13b

Mar 31 2021₹200m₹40k

₹13b

Dec 31 2020n/an/a

₹12b

Sep 30 2020n/an/a

₹12b

Jun 30 2020n/an/a

₹11b

Mar 31 2020₹200m₹40k

₹10b

Dec 31 2019n/an/a

₹6b

Sep 30 2019n/an/a

₹6b

Jun 30 2019n/an/a

₹5b

Mar 31 2019₹150m₹40k

₹4b

Dec 31 2018n/an/a

₹8b

Sep 30 2018n/an/a

₹6b

Jun 30 2018n/an/a

₹7b

Mar 31 2018₹150m₹40k

₹7b

Rémunération vs marché: La rémunération totale de Samir ($USD 3.08M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché Indian ($USD 1.10M ).

Rémunération et revenus: La rémunération de Samir a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.

PDG

Samir Mehta (60 yo)

35.8yrs

Titularisation

₹260,040,000

Compensation

Mr. Samir Uttamlal Mehta, B.Com., MBA serves as a Managing Director of Torrent Pharmaceuticals Limited since 1989. Mr. Mehta served as Managing Director of Torrent Power Limited. Mr. Mehta has been associa...

Équipe de direction

NomPositionTitularisationCompensationPropriété
Samir Mehta
Executive Chairman & MDno data₹260.04m0.00024%
₹ 2.6m
Aman Mehta
Whole-Time Director2.3yrs₹65.88m0.000060%
₹ 643.8k
Sudhir Menon
Chief Financial Officer6.2yrs₹16.30mpas de données
Chintan Trivedi
Company Secretary & Compliance Officer2.3yrspas de donnéespas de données
Jaydip Bhatt
Vice President of Human Resourceno data₹6.56mpas de données
Ashish Hajarnish
Executive Directorless than a year₹8.25mpas de données
Abdullah Said Al Abri
Chief Customer Service Officer3.4yrspas de donnéespas de données
Sanjay Gupta
President and CEO of Torrent Pharma USAno datapas de donnéespas de données

2.3yrs

Durée moyenne de l'emploi

58yo

Âge moyen

Gestion expérimentée: L'équipe de direction de TORNTPHARM est considérée comme expérimentée (ancienneté moyenne 2.3 ans).

Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Samir Mehta
Executive Chairman & MD35.8yrs₹260.04m0.00024%
₹ 2.6m
Aman Mehta
Whole-Time Director2.3yrs₹65.88m0.000060%
₹ 643.8k
Ashish Hajarnish
Executive Directorless than a year₹8.25mpas de données
Sudhir Mehta
Chairman Emeritus10.3yrspas de données0.00030%
₹ 3.2m
Nikhil Khattau
Independent Director1.1yrs₹2.60mpas de données
Manish Choksi
Independent Director2.3yrs₹4.30mpas de données
Ameera Shah
Independent Director6.3yrs₹4.90m0.00050%
₹ 5.4m
Nayantara Bali
Independent Director5.7yrs₹6.70mpas de données
Jinal Mehta
Non-Executive Directorless than a yearpas de donnéespas de données
Maurice Chagnaud
Independent Director2.5yrs₹6.30mpas de données

2.4yrs

Durée moyenne de l'emploi

58yo

Âge moyen

Conseil d'administration expérimenté: Le conseil d'administration de la TORNTPHARM n'est pas considéré comme expérimenté ( 2.4 années d'ancienneté moyenne), ce qui suggère un nouveau conseil d'administration.